HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of the antidotal efficacy of polyamincarboxylic acids (CDTA and DTPA) with time after acute zinc poisoning.

Abstract
The effect of increasing the time interval between acute zinc exposure and chelation therapy was studied in male Swiss mice. Cyclohexanediaminetetraacetic acid (CDTA), and diethylenetriaminepentaacetic acid (DTPA) were administered ip at 0, 0.25, 0.5, 2, 12, or 24 hr after ip administration of 0.40 mmol/kg of zinc acetate dihydrate. Chelating agents were given at doses equal to 1/3 of their respective LD50 values. Effectiveness of chelation therapy was determined by measuring the ability of the chelators to increase the elimination of zinc and decrease the concentration of the metal in various tissues. Treatment with DTPA or CDTA increased significantly the urinary and fecal excretion of zinc when the chelators were administered at various times following zinc exposure. The greatest antidotal efficacy of the chelating agents was observed at 0.50 hr after zinc injection. Nevertheless, the effectiveness of DTPA and CDTA was decreasing when the chelators were administered later. DTPA was more effective than CDTA in the prevention of acute zinc intoxication. CDTA would be considered as a possible alternative.
AuthorsJ M Llobet, M T Colomina, J L Domingo, J Corbella
JournalVeterinary and human toxicology (Vet Hum Toxicol) Vol. 31 Issue 1 Pg. 25-8 (Feb 1989) ISSN: 0145-6296 [Print] United States
PMID2496518 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chelating Agents
  • CDTA
  • Pentetic Acid
  • Edetic Acid
  • Zinc
Topics
  • Animals
  • Chelating Agents (administration & dosage, therapeutic use)
  • Edetic Acid (administration & dosage, analogs & derivatives, therapeutic use)
  • Feces (analysis)
  • Male
  • Mice
  • Pentetic Acid (administration & dosage, therapeutic use)
  • Time Factors
  • Tissue Distribution
  • Zinc (pharmacokinetics, poisoning, urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: